China FDA Clears Wosen Hib Vaccine In Infant’s Death
This article was originally published in PharmAsia News
Executive Summary
China's State FDA said a vaccine for pneumonia and meningitis was not at fault in the death of an infant girl in October. The agency said an investigation found nothing abnormal at the Wosen Biotechnology plant where the vaccine was produced. As a result, the drug bureau in Shandong where the death occurred lifted its ban on distribution and use of the hemophilus influenza type B vaccine. (Click here for more